Pioneering research to fight
pulmonary fibrosis and lung infection

Donate

J: What are the stages of pulmonary fibrosis?

Pulmonary fibrosis isn’t formally “staged,” but doctors often describe it as mild, moderate or severe based on symptoms, lung function and imaging. Forced Vital Capacity (FVC) helps guide this: above 80% is mild, 50 to 80% is moderate, and below 50% is severe. Disease progression varies—some remain stable, while others worsen more quickly.

 

🎥 Watch the Video: What are the stages of pulmonary fibrosis?

 

Professor Porter discusses the following:

 

Full Video Transcript

We’re often asked this and, to be honest, as clinicians, we don’t really ‘stage’ pulmonary fibrosis.

We recognise that there are patients with changes on the high resolution CT scan but no symptoms. These patients, strictly speaking, don’t have idiopathic pulmonary fibrosis or any sort of pulmonary fibrosis. But they have residual lung abnormalities, which we do need to keep an eye on to make sure they don’t progress.

But, once you actually have a diagnosis of interstitial lung disease or pulmonary fibrosis, we recognise early disease or mild disease, and then moderate disease, and then more severe disease. And, usually, we define whether you are mild, moderate or severe, depending on your symptoms and your lung function and your imaging.

But very, very crudely, if you have a forced vital capacity, which is one of the lung function tests, of above 80%, then we would say you have very ‘mild’ disease. If you have a lung function forced vital capacity of 50 to 80%, then we would say you have ‘moderate’ disease. And, if your forced vital capacity (or FVC) is less than 50%, then we would say you have ‘severe’ disease.  I think that’s a reasonably good demarcation in the stages of pulmonary fibrosis.

But, unlike other diseases, you don’t necessarily progress through the stages. You might have mild disease and stay mild, or you might very quickly progress to severe.

 

HOW YOU CAN HELP

Your support allows us to fund research into pulmonary fibrosis and other interstitial lung diseases.

Donate today to help improve the lives of those living with pulmonary fibrosis

 

 

 

[Video published December 2025]

 

 

 

Sign up to receive our news and updates

  • This form collects your name and email address so that we can keep you updated with news and information about Breathing Matters. Please check our Privacy Policy to see how we protect and manage your data.

Where there's research there's hope

Research into respiratory conditions accounts for just 2% of all the medical research funding in the UK.

Will you supportrespiratory research?